Disruption of the H-bonds by point-mutations at any of these residues, i.e., H119Y, F129L, or/and K57N (all of which are indeed detected in cancer cell lines or clinical cancers)17, sufficed to allow MEK1 to undergo autophosphorylation (Supplementary Fig. 4a–d). The gene discussed is MAP2K1; the disease is cancer.